Quantification of cefaclor in human plasma using SIL‐IS LC‐ESI‐MS/MS for pharmacokinetics study in healthy Chinese volunteers
Biomedical Chromatography · 2023
DOI: 10.1002/bmc.5638 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Xinyan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Wannan Medical College, Wuhu, Anhui, People's Republic of China. Hauptthemen laut MEDLINE: Cefaclor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Special Foundation for Talents of Yijishan Hospital, Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College, Funding of "Climbing Peak" Training Program for Innovation Technology Team of Yijishan Hospital, Wannan Medical College.
Abstract (Originalsprache)
A steady, high‐efficiency, and precise liquid chromatography‐electrospray ionization‐tandem mass spectrometry method was established and validated using cefaclor‐d5 as the stable isotope‐labeled internal standard for quantification of cefaclor in human plasma. One‐step protein precipitation was applied to extract human plasma samples using methanol as precipitant. An Ultimate XB C 18 column (2.1 × 50.0 mm, 5.0 μm) was used to achieve chromatographic separation. Mobile phases of gradient elution were an aqueous solution containing 0.1% formic acid (mobile phase A) and an acetonitrile solution containing 0.1% formic acid (mobile phase B). Electrospray ionization in positive‐ion mode was applied to detect under multiple reaction monitoring mode. Target fragment ion pairs of cefaclor and stable isotope‐labeled internal standard, respectively, were m/z 368.2 → 191.1 and m/z 373.2 → 196.1. Linear range of this method was between 20.0 and 10,000.0 ng/ml, with coefficient of determination ( R 2 ) >0.9900. Seven concentrations of quality control samples were used: 20.0 ng/ml (lower limit of quantitation), 60.0 ng/ml (low quality control), 650 ng/ml (middle quality control), 5000 ng/ml (arithmetic average middle quality control [AMQC]), 7500 ng/ml (high quality control), 10,000 ng/ml (upper limit of quantification), and 40,000 ng/ml (dilution quality control [DQC]). The method was validated for selectivity, lower limit of quantitation, linearity, accuracy, precision, recovery, matrix effect, dilution reliability, stability, carryover, and incurred sample reanalysis. This stable isotope‐labeled internal standard liquid chromatography‐electrospray ionization‐tandem mass spectrometry approach has been successfully applied to study the pharmacokinetics of cefaclor dry suspension among healthy Chinese volunteers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Wannan Medical College, Wuhu, Anhui, People's Republic of China.
- Anhui Provincial Center of Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, People's Republic of China.
ORCID-Profile: Xinyan Chen
Förderung
- Special Foundation for Talents of Yijishan Hospital
- Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital, Wannan Medical College
- Funding of "Climbing Peak" Training Program for Innovation Technology Team of Yijishan Hospital, Wannan Medical College
Zitieren
APA
Chen, X., Liu, G., Wang, C., Liu, R., Wang, M., Huang, Y., Shen, J., & Jia, Y. (2023). Quantification of cefaclor in human plasma using SIL‐IS LC‐ESI‐MS/MS for pharmacokinetics study in healthy Chinese volunteers. Biomedical Chromatography. https://doi.org/10.1002/bmc.5638
Vancouver
Chen X, Liu G, Wang C, Liu R, Wang M, Huang Y, et al. Quantification of cefaclor in human plasma using SIL‐IS LC‐ESI‐MS/MS for pharmacokinetics study in healthy Chinese volunteers. Biomedical Chromatography. 2023. doi:10.1002/bmc.5638
BibTeX
@article{Chen2023,
author = {Chen, Xinyan and Liu, Gege and Wang, Changmao and Liu, Ran and Wang, Minhui and Huang, Yunzhe and Shen, Jie and Jia, Yuanwei},
title = {Quantification of cefaclor in human plasma using SIL‐IS LC‐ESI‐MS/MS for pharmacokinetics study in healthy Chinese volunteers},
journal = {Biomedical Chromatography},
year = {2023},
doi = {10.1002/bmc.5638}
}
EUVIMED